Close inspection of data reveals that in several prostate tumors tested negative for the TMPRSS2:ERG rearrangement, TDRD1 is expressed at high levels despite low ERG expression, suggesting that ERG may not be the only factor which is capable of activating TDRD1 transcription. Here, ERG is linked to prostate neoplasm.